Jasper Therapeutics
Price & Volume
Stats
See more52W Range | $2.26-$26.05 |
Market Cap | $55.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.27 |
News
See moreYahoo Finance • 3 days ago
Jasper Therapeutics cuts workforce by 50% to focus on urticaria programs
Yahoo Finance • 3 days ago
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
Yahoo Finance • 4 days ago
Jasper Therapeutics stock downgraded by BMO Capital on CSU trial concerns
Yahoo Finance • 4 days ago
Jasper Therapeutics stock price target lowered to $20 by Evercore ISI
About
CEO | Mr. Ronald A. Martell |
CFO | Mr. Herbert C. Cross CPA |
Address | 2200 Bridge Pkwy, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
